Selected research
Industry Research
IV Administration Primary Set Industry Research Report 2026
Market perspective
The global IV Administration Primary Set market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for IV Administration Primary Set is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for IV Administration Primary Set is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for IV Administration Primary Set is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of IV Administration Primary Set include BD, SB Kawasumi, Amsino, Bayer, Baxter International, Zyno Medical, Smiths Medical, MPS Medical and Medtec Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global IV Administration Primary Set market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
IV Administration Primary Set Market by Company
BD
SB Kawasumi
Amsino
Bayer
Baxter International
Zyno Medical
Smiths Medical
MPS Medical
Medtec Medical
MedSource Labs
ICU Medical
Eitan Group
CODAN US Corporation
B. Braun
Advanced Medical Systems
3M
IV Administration Primary Set Segment by Type
1 - 200 Micron
More Than 200 Micron
Less Than 1 Micron
IV Administration Primary Set Segment by Application
Hospitals
Clinics
Other
IV Administration Primary Set Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IV Administration Primary Set market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of IV Administration Primary Set and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IV Administration Primary Set.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of IV Administration Primary Set manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of IV Administration Primary Set by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of IV Administration Primary Set in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1 - 200 Micron
- More Than 200 Micron
- Less Than 1 Micron
Applications
- Hospitals
- Clinics
- Other
Companies covered
- BD
- SB Kawasumi
- Amsino
- Bayer
- Baxter International
- Zyno Medical
- Smiths Medical
- MPS Medical
- Medtec Medical
- MedSource Labs
- ICU Medical
- Eitan Group
- CODAN US Corporation
- B. Braun
- Advanced Medical Systems
- 3M
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global IV Administration Primary Set Market Size (2021-2032)
- 2.2.2 Global IV Administration Primary Set Sales (2021-2032)
- 2.2.3 Global IV Administration Primary Set Market Average Price (2021-2032)
- 2.3 IV Administration Primary Set by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1 - 200 Micron
- 2.3.3 More Than 200 Micron
- 2.3.4 Less Than 1 Micron
- 2.4 IV Administration Primary Set by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global IV Administration Primary Set Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global IV Administration Primary Set Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global IV Administration Primary Set Revenue of Manufacturers (2021-2026)
- 3.4 Global IV Administration Primary Set Average Price by Manufacturers (2021-2026)
- 3.5 Global IV Administration Primary Set Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of IV Administration Primary Set, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of IV Administration Primary Set, Product Type & Application
- 3.8 Global Manufacturers of IV Administration Primary Set, Established Date
- 3.9 Global IV Administration Primary Set Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 BD
- 4.1.1 BD Company Information
- 4.1.2 BD Business Overview
- 4.1.3 BD IV Administration Primary Set Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 BD IV Administration Primary Set Product Portfolio
- 4.1.5 BD Recent Developments
- 4.2 SB Kawasumi
- 4.2.1 SB Kawasumi Company Information
- 4.2.2 SB Kawasumi Business Overview
- 4.2.3 SB Kawasumi IV Administration Primary Set Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 SB Kawasumi IV Administration Primary Set Product Portfolio
- 4.2.5 SB Kawasumi Recent Developments
- 4.3 Amsino
- 4.3.1 Amsino Company Information
- 4.3.2 Amsino Business Overview
- 4.3.3 Amsino IV Administration Primary Set Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Amsino IV Administration Primary Set Product Portfolio
- 4.3.5 Amsino Recent Developments
- 4.4 Bayer
- 4.4.1 Bayer Company Information
- 4.4.2 Bayer Business Overview
- 4.4.3 Bayer IV Administration Primary Set Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bayer IV Administration Primary Set Product Portfolio
- 4.4.5 Bayer Recent Developments
- 4.5 Baxter International
- 4.5.1 Baxter International Company Information
- 4.5.2 Baxter International Business Overview
- 4.5.3 Baxter International IV Administration Primary Set Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Baxter International IV Administration Primary Set Product Portfolio
- 4.5.5 Baxter International Recent Developments
- 4.6 Zyno Medical
- 4.6.1 Zyno Medical Company Information
- 4.6.2 Zyno Medical Business Overview
- 4.6.3 Zyno Medical IV Administration Primary Set Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Zyno Medical IV Administration Primary Set Product Portfolio
- 4.6.5 Zyno Medical Recent Developments
- 4.7 Smiths Medical
- 4.7.1 Smiths Medical Company Information
- 4.7.2 Smiths Medical Business Overview
- 4.7.3 Smiths Medical IV Administration Primary Set Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Smiths Medical IV Administration Primary Set Product Portfolio
- 4.7.5 Smiths Medical Recent Developments
- 4.8 MPS Medical
- 4.8.1 MPS Medical Company Information
- 4.8.2 MPS Medical Business Overview
- 4.8.3 MPS Medical IV Administration Primary Set Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 MPS Medical IV Administration Primary Set Product Portfolio
- 4.8.5 MPS Medical Recent Developments
- 4.9 Medtec Medical
- 4.9.1 Medtec Medical Company Information
- 4.9.2 Medtec Medical Business Overview
- 4.9.3 Medtec Medical IV Administration Primary Set Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Medtec Medical IV Administration Primary Set Product Portfolio
- 4.9.5 Medtec Medical Recent Developments
- 4.10 MedSource Labs
- 4.10.1 MedSource Labs Company Information
- 4.10.2 MedSource Labs Business Overview
- 4.10.3 MedSource Labs IV Administration Primary Set Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 MedSource Labs IV Administration Primary Set Product Portfolio
- 4.10.5 MedSource Labs Recent Developments
- 4.11 ICU Medical
- 4.11.1 ICU Medical Company Information
- 4.11.2 ICU Medical Business Overview
- 4.11.3 ICU Medical IV Administration Primary Set Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 ICU Medical IV Administration Primary Set Product Portfolio
- 4.11.5 ICU Medical Recent Developments
- 4.12 Eitan Group
- 4.12.1 Eitan Group Company Information
- 4.12.2 Eitan Group Business Overview
- 4.12.3 Eitan Group IV Administration Primary Set Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Eitan Group IV Administration Primary Set Product Portfolio
- 4.12.5 Eitan Group Recent Developments
- 4.13 CODAN US Corporation
- 4.13.1 CODAN US Corporation Company Information
- 4.13.2 CODAN US Corporation Business Overview
- 4.13.3 CODAN US Corporation IV Administration Primary Set Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 CODAN US Corporation IV Administration Primary Set Product Portfolio
- 4.13.5 CODAN US Corporation Recent Developments
- 4.14 B. Braun
- 4.14.1 B. Braun Company Information
- 4.14.2 B. Braun Business Overview
- 4.14.3 B. Braun IV Administration Primary Set Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 B. Braun IV Administration Primary Set Product Portfolio
- 4.14.5 B. Braun Recent Developments
- 4.15 Advanced Medical Systems
- 4.15.1 Advanced Medical Systems Company Information
- 4.15.2 Advanced Medical Systems Business Overview
- 4.15.3 Advanced Medical Systems IV Administration Primary Set Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Advanced Medical Systems IV Administration Primary Set Product Portfolio
- 4.15.5 Advanced Medical Systems Recent Developments
- 4.16 3M
- 4.16.1 3M Company Information
- 4.16.2 3M Business Overview
- 4.16.3 3M IV Administration Primary Set Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 3M IV Administration Primary Set Product Portfolio
- 4.16.5 3M Recent Developments
5 Global IV Administration Primary Set Market Scenario by Region
- 5.1 Global IV Administration Primary Set Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global IV Administration Primary Set Sales by Region: 2021-2032
- 5.2.1 Global IV Administration Primary Set Sales by Region: 2021-2026
- 5.2.2 Global IV Administration Primary Set Sales by Region: 2027-2032
- 5.3 Global IV Administration Primary Set Revenue by Region: 2021-2032
- 5.3.1 Global IV Administration Primary Set Revenue by Region: 2021-2026
- 5.3.2 Global IV Administration Primary Set Revenue by Region: 2027-2032
- 5.4 North America IV Administration Primary Set Market Facts & Figures by Country
- 5.4.1 North America IV Administration Primary Set Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America IV Administration Primary Set Sales by Country (2021-2032)
- 5.4.3 North America IV Administration Primary Set Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe IV Administration Primary Set Market Facts & Figures by Country
- 5.5.1 Europe IV Administration Primary Set Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe IV Administration Primary Set Sales by Country (2021-2032)
- 5.5.3 Europe IV Administration Primary Set Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific IV Administration Primary Set Market Facts & Figures by Country
- 5.6.1 Asia Pacific IV Administration Primary Set Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific IV Administration Primary Set Sales by Country (2021-2032)
- 5.6.3 Asia Pacific IV Administration Primary Set Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America IV Administration Primary Set Market Facts & Figures by Country
- 5.7.1 South America IV Administration Primary Set Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America IV Administration Primary Set Sales by Country (2021-2032)
- 5.7.3 South America IV Administration Primary Set Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa IV Administration Primary Set Market Facts & Figures by Country
- 5.8.1 Middle East and Africa IV Administration Primary Set Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa IV Administration Primary Set Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa IV Administration Primary Set Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global IV Administration Primary Set Sales by Type (2021-2032)
- 6.1.1 Global IV Administration Primary Set Sales by Type (2021-2032) & (k units)
- 6.1.2 Global IV Administration Primary Set Sales Market Share by Type (2021-2032)
- 6.2 Global IV Administration Primary Set Revenue by Type (2021-2032)
- 6.2.1 Global IV Administration Primary Set Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global IV Administration Primary Set Revenue Market Share by Type (2021-2032)
- 6.3 Global IV Administration Primary Set Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global IV Administration Primary Set Sales by Application (2021-2032)
- 7.1.1 Global IV Administration Primary Set Sales by Application (2021-2032) & (k units)
- 7.1.2 Global IV Administration Primary Set Sales Market Share by Application (2021-2032)
- 7.2 Global IV Administration Primary Set Revenue by Application (2021-2032)
- 7.2.1 Global IV Administration Primary Set Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global IV Administration Primary Set Revenue Market Share by Application (2021-2032)
- 7.3 Global IV Administration Primary Set Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 IV Administration Primary Set Value Chain Analysis
- 8.1.1 IV Administration Primary Set Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 IV Administration Primary Set Production Mode & Process
- 8.2 IV Administration Primary Set Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 IV Administration Primary Set Distributors
- 8.2.3 IV Administration Primary Set Customers
9 Global IV Administration Primary Set Analyzing Market Dynamics
- 9.1 IV Administration Primary Set Industry Trends
- 9.2 IV Administration Primary Set Industry Drivers
- 9.3 IV Administration Primary Set Industry Opportunities and Challenges
- 9.4 IV Administration Primary Set Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst